HRTX Heron Therapeuti
Company Analysis
Latest News
🟢 Heron Therapeutics is trading 12.49% up in pre-market with no confirmed catalyst
Heron Therapeutics is trading at $0.33, up 12.49%, in pre-market with no confirmed catalyst. - No new company-specific announcement explaining the October 23...
🔴 Heron Therapeutics is trading 10% down today as oil jumps amid Strait of Hormuz tensions
Heron Therapeutics is trading at $0.30 (-10.01%), with broader risk-off trading coinciding with oil-price gains amid Strait of Hormuz tensions. - No...
🔴 Heron Therapeutics is trading 10.3% down amid broad risk-off trading
Heron Therapeutics is trading 10.27% down at $0.30 amid broad risk-off trading. - No company-specific announcement for October 22, 2026, was identified;...
🔴 Heron Therapeutics is trading 7.6% down today amid broader market declines
Heron Therapeutics is trading at $0.31, down 7.62%, with broad market weakness the likeliest explanation; no source directly attributes the move to it. - No...
🔴 Heron Therapeutics is trading 6% down today
Heron Therapeutics is trading 5.92% lower at $0.33, with no clear catalyst identified. - No new company announcement was listed on its investor-relations news...
🟢 Heron Therapeutics rises 5.4% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 Heron Therapeutics falls 5.0% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🟢 Heron Therapeutics is trading 9.5% up today alongside a 2.20% gain in biotech
Heron Therapeutics is trading at $0.40, up +9.50%, alongside a 2.20% gain in biotech (XBI). - No clear Heron Therapeutics-specific announcement explaining the...
🔴 Heron Therapeutics is trading 5.3% down today amid rate concerns after hotter-than-expected inflation
Heron Therapeutics is trading 5.25% lower at $0.37, possibly pressured by broader-market weakness after hotter-than-expected September inflation. - September...
🔴 Heron Therapeutics is trading 6% down with no direct catalyst identified
Heron Therapeutics is trading at $0.39, down -5.85%, with no direct catalyst identified. - No new company-specific announcement was identified for October 13,...
🔴 Heron Therapeutics is trading 5% down
Heron Therapeutics is trading at $0.39, down 5.10%, with no clear company-specific catalyst identified at 10:26 a.m. ET on October 12, 2026. - Heron’s...
🟢 Heron Therapeutics is trading 10.25% up with no identified company-specific catalyst
Heron Therapeutics is trading up 10.25% at $0.39 on October 9, 2026, with no direct company-specific catalyst identified. - The supplied context reports XBI up...
🟢 Heron Therapeutics is trading 7.31% up; no direct catalyst identified
Heron Therapeutics is trading at $0.38, up 7.31%, and available sources do not establish a direct cause for the October 9 gain. - No company-specific...
🔴 Heron Therapeutics is trading 5% down
Heron Therapeutics is trading at $0.36, down 5.36%, with no clear company-specific catalyst identified for the October 8 decline. - Heron’s news page lists...
🔴 Heron Therapeutics is trading 5% down in pre-market
Heron Therapeutics is trading at $0.36, down 5.41% in pre-market, with no clear company-specific catalyst identified. - The company’s official news page lists...
🔴 Heron Therapeutics is trading 5% down in after-hours trading
Heron Therapeutics is trading at $0.36, down 5.02% in after-hours trading, with no clear company-specific announcement or late-breaking catalyst identified for...
🟢 Heron Therapeutics is trading 11% up today; no clear catalyst identified
Heron Therapeutics is trading at $0.37, up 11.28%, with no fresh company-specific catalyst identified for the October 7 move. - The broader market and biotech...
🟢 Heron Therapeutics is trading 5% up today with no identified company-specific catalyst
Heron Therapeutics is trading at $0.35, up 5.49%, with no fresh company-specific catalyst identified. - Shares fell 10.35% to $0.33 on October 6; the company’s...
🟢 Heron Therapeutics is trading 5% up in pre-market with no identified company-specific catalyst
Heron Therapeutics is trading 5.28% higher at $0.35 in pre-market on October 7, 2026, with no fresh company-specific announcement identified to explain the...
🔴 Heron Therapeutics is trading 10% down today amid biotech-sector weakness
Heron Therapeutics is trading at $0.33, down 10.05%, amid biotech-sector pressure. - No fresh company-specific announcement explaining the October 6 decline...